| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/03/2008 | CN101254191A Use of quinazoline glyoxaline compounds |
| 09/03/2008 | CN101254182A Hypertension-treating medicine combination |
| 09/03/2008 | CN101254181A Hypertension-treating medicine combination |
| 09/03/2008 | CN101254180A Nimodipine capsule containing semi-solid combination and preparation |
| 09/03/2008 | CN101254175A Boletic acid buddhist nun azoles phenyl ketone freeze-dried powder and method of preparing the same |
| 09/03/2008 | CN101253984A Royal jelly ginkgo leaf nutrition health products and method of preparing the same |
| 09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
| 09/03/2008 | CN100415734C 1-acetoxy-3-(substituted phenyl) propen compounds useful as an intermediate material |
| 09/03/2008 | CN100415724C Pyrimidine derivatives |
| 09/03/2008 | CN100415723C Benzimidazole derivative |
| 09/03/2008 | CN100415719C 2,5-disubstituted 3-mercaptopentanoic acid |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/03/2008 | CN100415709C Beta-(3,4) dihydroxy phenyl-alpha hydroxy borneol propionate, its synthesis method and use |
| 09/03/2008 | CN100415262C Medicine for treating cerebral infraction and its preparing method |
| 09/03/2008 | CN100415259C Medicine for treating coronary heart disease and preparation thereof |
| 09/03/2008 | CN100415244C Nasal drip liquor for treating rhinitis and nasosinusitis |
| 09/03/2008 | CN100415241C Medicinal composition for treating cardio-cerebrovascular diseases |
| 09/03/2008 | CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection |
| 09/03/2008 | CN100415226C Electrolyte replenisher for treating hypopotassaemia hypomagnesemia and its uses |
| 09/03/2008 | CN100415221C Curcumin lyophilized liposome for injection and its preparing method |
| 09/03/2008 | CN100415215C Wild camellia seed oil soft capsule |
| 09/02/2008 | US7420100 Animal model lacking histone deacetylase (HDAC) for use as diagnostic tool in detection, diagnosis and prevention of cardiac hypertrophy |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420042 Soluble neuropilin/growth factor receptor fusion proteins |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419998 Therapeutic methods and compositions involving isoflavones |
| 09/02/2008 | US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419977 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2- alpha ]quinoline-2-carbonyl)morpholine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
| 09/02/2008 | US7419956 Isolated physiologically active peptide and use thereof |
| 09/02/2008 | US7419955 Especially from intimal thickening, by administering a C-terminal globular domain of adiponectin to down-regulate expression of scavenger receptor A |
| 09/02/2008 | US7419952 Use of exendins and agonists thereof to treat diabetes |
| 09/02/2008 | US7419950 Methods of inhibiting ectopic calcification |
| 09/02/2008 | US7419814 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/02/2008 | US7419799 Medical diagnosis; gene expression; genetic engineering; cell proliferation |
| 09/02/2008 | US7419678 Coated medical devices for the prevention and treatment of vascular disease |
| 09/02/2008 | US7419670 Method of treating arthritis with SERP-1 and an immunosuppressant |
| 09/02/2008 | US7419657 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines |
| 09/02/2008 | CA2440468C Pregabalin lactose conjugates |
| 09/02/2008 | CA2389333C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 09/02/2008 | CA2388140C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 09/02/2008 | CA2356158C Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| 09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 09/02/2008 | CA2169696C Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them |
| 09/01/2008 | CA2580100A1 Treatment of endothelial dysfunction in diabetic patients |
| 08/28/2008 | WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/28/2008 | WO2008103336A1 Methods for intravascular engraftment in heart |
| 08/28/2008 | WO2008102777A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008102563A1 Therapeutic or prophylactic agent for vasoconstriction |
| 08/28/2008 | WO2008102036A1 Method for obtaining a freeze-dried, stable extract from plants of the allium genus |
| 08/28/2008 | WO2008101724A1 Use of riboflavin in the treatment of hypertension |
| 08/28/2008 | WO2008101375A1 A gastric retentive sustained-release pharmaceutical composition comprising irbesartan |
| 08/28/2008 | WO2008045961A3 Compositions and methods of administering rapamycin analogs with paclitaxel using medical devices |
| 08/28/2008 | WO2008043461A3 Inhibition of pde2a |
| 08/28/2008 | WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 08/28/2008 | WO2007073497A3 Calcium channel antagonists |
| 08/28/2008 | US20080208167 Methods and compositions to treat myocardial conditions |
| 08/28/2008 | US20080207902 Phosphodiesterase inhibitors; side effect reduction |
| 08/28/2008 | US20080207899 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction |
| 08/28/2008 | US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
| 08/28/2008 | US20080207726 Reacting carvediol with phosphoric acid; precipitating ; reducing impurities. |
| 08/28/2008 | US20080207716 Formulations and Dosing Regiment for Ppar-Alpha Modulators |
| 08/28/2008 | US20080207702 Use of Quaternary Pyridinium Salts as Vasoprotective Agents |
| 08/28/2008 | US20080207685 Heterocyclic Compounds As Modulators Of Peroxisome Proliferator Activated Receptors, Useful For The Treatment And/Or Prevention Of Disorders Modulated By A Ppar |
| 08/28/2008 | US20080207681 Perfusion blood through tube coated with collagen; measure thrombosis and platelet aggregation; prevent cardiovascular disorders |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 08/28/2008 | US20080207646 Prevent collagen synthesis in liver cells; increase blood flow through portal vein; cirrhosis; long half-life |
| 08/28/2008 | US20080207643 Composition for Treating Hyperlipaemia |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207635 Tyrosine kinase moderators; anticancer agents; antidiabetic agents; restenosis; arteriosclerosis ; skin disorders; |
| 08/28/2008 | US20080207629 Liquid preparation comprising pimobendan |
| 08/28/2008 | US20080207622 Soluble epoxide hydrolase inhibitors |
| 08/28/2008 | US20080207621 Use treating hypertensive, cardiovascular, inflammatory, pulmonary, and diabetes-related diseases; compounds are aminosulfonylphenyl urea or thiourea e.g. 4-(3-Adamantan-1-yl-ureido)-N-(2-morpholin-4-yl-ethyl)-benzenesulfonamide |
| 08/28/2008 | US20080207612 Analgesics; pain management |
| 08/28/2008 | US20080207611 Anticancer agents; kinase inhibitors; viricides; antiinflammatory agents; immunotherapy; metabolism disorders |
| 08/28/2008 | US20080207609 Anticancer agents; kinase inhibitor; immunotherapy; viricides; antiinflammatory agents |
| 08/28/2008 | US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects |
| 08/28/2008 | US20080207585 Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof |
| 08/28/2008 | US20080207552 Decoy compositions for treating and preventing brain diseases and disorders |
| 08/28/2008 | US20080207507 Hypoglycemic agents; antidiabetic agents ; hypotensive agents; cardiovascular disorders; strokes; antiinflammatory agents; antiulcer agents; glucangon-like peptide |
| 08/28/2008 | US20080207505 Diuretics; hypotensive agents; congestive heart failure; stimulate cyclic guanosine 3",5"-monophosphate |
| 08/28/2008 | US20080207503 Composition and Treatment Methods for Coronary Artery Disease |
| 08/28/2008 | US20080207501 Therapy for metabolism disorders, cardiovascular disorders, obesity, antidiabetic agents |
| 08/28/2008 | US20080207499 Rage-related methods for treating and preventing diabetic retinopathy |
| 08/28/2008 | US20080206376 Methods and compositions for inhibiting angiotensin converting and chymase enzymes |
| 08/28/2008 | US20080206375 Composition of Radix Codonopsis and Radix Astragali, a Method for Preparation Thereof and its Application |
| 08/28/2008 | US20080206374 Purification, washing with deionized water, heating and extracting, condensing, depositing with ethanol; immunomodulators, antiischemic agents |
| 08/28/2008 | US20080206352 Extract for Preventing or Treating Thrombotic Diseases |
| 08/28/2008 | US20080206348 Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers |
| 08/28/2008 | US20080206312 Therapeutic Morpholino-Substituted Compounds |
| 08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
| 08/28/2008 | US20080206247 Glycoprotein VI fusion proteins |
| 08/28/2008 | US20080206223 Treatment of pompe's disease |
| 08/28/2008 | US20080206208 Adipose tissue culture use in treatment and prevention of cardiomyopathies; tissue engineering; regenerative medicine |
| 08/28/2008 | US20080206150 Nanoparticles for Imaging Atherosclerotic Plaque |
| 08/28/2008 | US20080206142 Use to treat dyslipidemic disorders, stroke and myocardial infarction; detecting plaque in vessels using the labeled peptides; peptides with apolipoprotein A-I (apoA-I) domains |
| 08/28/2008 | DE102007010306A1 Bispezifisches Fusionsprotein mit therapeutischem und diagnostischem Potenzial The bispecific fusion protein with therapeutic and diagnostic potential |